Northstar Group Inc. Sells 368 Shares of Johnson & Johnson (JNJ)

Fort Point Capital Partners LLC raised its position in shares of Johnson & Johnson by 124.0% in the third quarter. The Finemark National Bank & Trust holds 88,433 shares with $10.19M value, up from 85,821 last quarter. Johnson & Johnson now has $368.38B valuation. The stock increased 0.85% or $1.14 during the last trading session, reaching $136.05. Harbour Capital Advisors, LLC divested its investment by selling 1,889 shares a decrease of 15.6% from 06/30/2013 to 03/31/2013. It is down 0.00% since June 23, 2016 and is. It has underperformed by 4.16% the S&P500. Stewart West Indies Trading Comm Limited reported 250,000 shares. Macquarie Group Ltd. now owns 6,851,198 shares of the company's stock valued at $789,328,000 after buying an additional 362,616 shares during the period. Empirical Finance LLC bought a new position in Johnson & Johnson during the fourth quarter valued at about $144,000. Gnc Hldgs Inc now has $508.51M valuation. The stock declined 0.39% or $0.53 reaching $135.52 on the news. About 233,290 shares traded. Analogic Corporation (NASDAQ:ALOG) has declined 8.54% since June 23, 2016 and is downtrending. It has underperformed by 87.39% the S&P500.

Since February 1, 2017, it had 0 buys, and 5 sales for $14.98 million activity.

Among 4 analysts covering Endocyte (NASDAQ:ECYT), 2 have Buy rating, 0 Sell and 2 Hold. Page Arthur B holds 5.14% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 46,704 shares. $2.45 million worth of stock was sold by Ullmann Michael H on Wednesday, February 1. Duato Joaquin also sold $6.18M worth of Johnson & Johnson (NYSE:JNJ) on Friday, March 3. The North Carolina-based Schaller Grp Inc has invested 0.18% in Johnson & Johnson (NYSE:JNJ). Lenox Wealth Advisors Inc. increased its stake in Johnson & Johnson by 0.7% in the first quarter. Its down 0.05, from 1.03 in 2016Q3. It improved, as 63 investors sold Johnson & Johnson shares while 834 reduced holdings. Primecap Mgmt Commerce Ca stated it has 2.17 million shares. American Investment Services Inc. bought a new stake in shares of Johnson & Johnson during the first quarter valued at $219,000. Deutsche Bank & Trust Ag owns 412,252 shares or 0.03% of their USA portfolio. Advantus Cap Mgmt has invested 0.84% of its portfolio in Johnson & Johnson (NYSE:JNJ). Cv Starr & Inc Tru stated it has 40,000 shares or 1.97% of all its holdings. Johnson & Johnson (JNJ) is a part of Healthcare sector and belongs to Drug Manufacturers - Major industry. Lenox Wealth Advisors Inc. now owns 871 shares of the company's stock valued at $108,000 after buying an additional 6 shares during the last quarter. Norinchukin Retail Bank The reported 0.89% stake. Independence owns 28,361 shares. Point72 Asset Lp accumulated 0.2% or 245,700 shares. Park Oh has 366,332 shares for 2.57% of their portfolio. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, July 20. Stonebridge Advsrs Limited Liability Corp invested 1.73% of its portfolio in Johnson & Johnson (NYSE:JNJ). BMO Capital Markets restated a "buy" rating and issued a $132.00 price target on shares of Johnson & Johnson in a report on Friday, June 2nd. Therefore 50% are positive. BidaskClub raised shares of Johnson & Johnson from a "buy" rating to a "strong-buy" rating in a research note on Saturday, June 17th. Argus Research upgraded the stock and lowered the price target on July 20 cutting the price target from $114.00 to $113.00 and changing the rating from "Neutral" to "Hold". Cowen & Co downgraded the stock to "Market Perform" rating in Monday, June 5 report. The firm earned "Equal-Weight" rating on Tuesday, November 29 by Barclays Capital. BTIG Research reissued a "hold" rating on shares of Johnson & Johnson in a report on Wednesday, April 19th. The firm earned "Hold" rating on Tuesday, September 13 by Jefferies. The company had revenue of $17.77 billion during the quarter, compared to analyst estimates of $18.02 billion. $12,204 worth of stock was sold by Ryan James Patrick on Thursday, June 15. Hewitt Dennis E. sold $119,197 worth of stock. Shareholders of record on Tuesday, May 30th were paid a $0.84 dividend. The company reported $1.83 earnings per share for the quarter, beating analysts' consensus estimates of $1.77 by $0.06. Its down 60.42% from 14,400 shares previously. During the same quarter in the previous year, the company posted $1.68 EPS. Therefore 25% are positive. Johnson & Johnson had 44 analyst reports since August 7, 2015 according to SRatingsIntel. The company presently has a consensus rating of "Buy" and a consensus target price of $131.17. Goldman Sachs upgraded the shares of JNJ in report on Monday, March 14 to "Neutral" rating. Telsey Advisory Group maintained the stock with "Market Perform" rating in Wednesday, July 20 report.

Investors sentiment decreased to 0.75 in 2016 Q4.

The stock has shown weekly performance of -0.11% and monthly performance stands at 1.32%. It is positive, as 14 investors sold ALOG shares while 49 reduced holdings. 13 funds opened positions while 27 raised stakes. Manufacturers Life The holds 224,067 shares or 0.01% of its portfolio. Veritas Inv Mngmt (Uk) accumulated 2,860 shares. Princeton Alpha Management Limited Partnership owns 24,406 shares for 0.43% of their portfolio. Stellar Cap Mngmt Lc owns 27,493 shares or 2.6% of their United States portfolio. Spinnaker Trust sold 3,274 shares as Johnson & Johnson (JNJ)'s stock rose 6.85%.

  • Zachary Reyes